Overview

Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea

Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
This study was designed to determine efficacy of TREXIMA compared to placebo for the treatment of a menstrual migraine.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Naproxen
Sumatriptan